COVID-19 | Page 6 | Pathology & Laboratory Medicine

Hofbauer Cells and COVID-19 in Pregnancy.

Schwartz DA, Baldewijns M, Benachi A, Bugatti M, Bulfamante G, Cheng K, Collins RRJ, Debelenko L, De Luca D, Facchetti F et al.. 2021. Hofbauer Cells and COVID-19 in Pregnancy.. Arch Pathol Lab Med. 145(11):1328-1340.

Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays.

Velu P, Cong L, Rand S, Qiu Y, Zhang Z, Zhang J, Guo J, Ruggiero P, Sukhu A, Fauntleroy K et al.. 2022. Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays.. Diagn Microbiol Infect Dis. 104(4):115789.

Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.

Guerrero-Preston R, Rivera-Amill V, Caraballo K, Rodriguez-Torres S, Purcell-Wiltz A, García AA, Torres RS, Zamuner FT, Zanettini C, MacKay MJ et al.. 2022. Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.. Immun Inflamm Dis. 10(6):e634.

Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City.

Satlin MJ, Zucker J, Baer BR, Rajan M, Hupert N, Schang LM, Pinheiro LC, Shen Y, Sobieszczyk ME, Westblade LF et al.. 2021. Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City.. PLoS One. 16(11):e0257979.

Evolution of Antibody Immunity to SARS-CoV-2.

Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY et al.. 2021. Evolution of Antibody Immunity to SARS-CoV-2.. bioRxiv.

Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year.

Wang Z, Muecksch F, Schaefer-Babajew D, Finkin S, Viant C, Gaebler C, Hoffmann H-H, Barnes CO, Cipolla M, Ramos V et al.. 2021. Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year.. bioRxiv.

Evolution of antibody immunity to SARS-CoV-2.

Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY et al.. 2021. Evolution of antibody immunity to SARS-CoV-2.. Nature. 591(7851):639-644.

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.

Wang Z, Muecksch F, Schaefer-Babajew D, Finkin S, Viant C, Gaebler C, Hoffmann H-Heinrich, Barnes CO, Cipolla M, Ramos V et al.. 2021. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.. Nature. 595(7867):426-431.

Serologic response to mRNA COVID-19 vaccination in lymphoma patients.

Jurgens EMatthew, Ketas TJoseph, Zhao Z, Satlin MJoseph, Small CButkus, Sukhu A, Francomano E, Klasse PJohan, Garcia A, Nguyenduy E et al.. 2021. Serologic response to mRNA COVID-19 vaccination in lymphoma patients.. Am J Hematol. 96(11):E410-E413.

Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study.

Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, Kubiak JM, Yang YJ, Zhao Z, Baergen RN, DiPace JI et al.. 2020. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study.. BJOG. 127(12):1548-1556.